These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 38865858)
1. Novel acyl hydrazide derivatives of polyhydroquinoline as potent anti-diabetic and anti-glycating agents: Synthesis, in vitro α-amylase, α-glucosidase inhibition and anti-glycating activity with molecular docking insights. Ur Rahman S; Alam A; Parveen Z; Zainab ; Assad M; Adnan Ali Shah S; Rafiq H; Ayaz M; Latif A; Naveed Umar M; Ali M; Ahmad M Bioorg Chem; 2024 Sep; 150():107501. PubMed ID: 38865858 [TBL] [Abstract][Full Text] [Related]
2. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation. Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-γ Agonists, α-Glucosidase, α-Amylase and COX-2 inhibitors; Design, synthesis and in silico study. Fadaly WAA; Elshewy A; Nemr MTM; Abdou K; Sayed AM; Kahk NM Bioorg Chem; 2024 Nov; 152():107760. PubMed ID: 39197383 [TBL] [Abstract][Full Text] [Related]
4. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation. Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516 [TBL] [Abstract][Full Text] [Related]
5. Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation. Luo S; Zhao L; Peng H; Peng Z; Wang G Eur J Med Chem; 2024 Sep; 275():116600. PubMed ID: 38889608 [TBL] [Abstract][Full Text] [Related]
6. Isatin-hydrazide conjugates as potent α-amylase and α-glucosidase inhibitors: Synthesis, structure and invitro evaluations. Abbasi I; Nadeem H; Saeed A; Kharl HAA; Tahir MN; Naseer MM Bioorg Chem; 2021 Nov; 116():105385. PubMed ID: 34600331 [TBL] [Abstract][Full Text] [Related]
7. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus. Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose. Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132 [TBL] [Abstract][Full Text] [Related]
9. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies. Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122 [TBL] [Abstract][Full Text] [Related]
11. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation. Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978 [TBL] [Abstract][Full Text] [Related]
12. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting Gohar NA; Fayed EA; A Ammar Y; A Abu Ali O; Ragab A; Mahfoz AM; Abusaif MS J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2367128. PubMed ID: 38913598 [TBL] [Abstract][Full Text] [Related]
13. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition. Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies. Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies. Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920 [TBL] [Abstract][Full Text] [Related]
16. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies. Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353 [TBL] [Abstract][Full Text] [Related]
17. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study. Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520 [TBL] [Abstract][Full Text] [Related]
18. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents. Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703 [TBL] [Abstract][Full Text] [Related]
20. Facile synthesis and Punia R; Mor S; Khatri M; Kumar D; Das PP; Jindal DK; Kumar A; Selvaraj P; Kumar R; Mohil R; Jakhar K Future Med Chem; 2024; 16(10):999-1027. PubMed ID: 38910576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]